WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008094617) CRYSTALLINE FORMS OF DEFERASIROX
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/094617    International Application No.:    PCT/US2008/001252
Publication Date: 07.08.2008 International Filing Date: 29.01.2008
IPC:
C07D 249/08 (2006.01), A61K 31/4196 (2006.01), A61P 7/00 (2006.01)
Applicants: TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság [HU/HU]; Pallagi ut 13, H-4042 Debrecen (HU) (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BE, BF, BG, BH, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MG, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SV, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW only).
TEVA PHARMACEUTICALS USA, INC. [US/US]; 1090 HORSHAM ROAD, P.O. Box 1090, North Wales, Pennsylvania 19454-1090 (US) (BB only).
TOTH, Zoltan, G. [HU/HU]; (HU) (For US Only).
TAMAS, Tivadar [HU/HU]; (HU) (For US Only).
RACZ, Csilla, Nemethne [HU/HU]; (HU) (For US Only)
Inventors: TOTH, Zoltan, G.; (HU).
TAMAS, Tivadar; (HU).
RACZ, Csilla, Nemethne; (HU)
Agent: BIRDE, Patrick, J.; KENYON & KENYON LLP, One Broadway, New York, NY 10004-1050 (US)
Priority Data:
60/898,368 29.01.2007 US
60/919,428 21.03.2007 US
60/994,223 17.09.2007 US
Title (EN) CRYSTALLINE FORMS OF DEFERASIROX
(FR) FORMES CRISTALLINES DE DÉFÉRASIROX
Abstract: front page image
(EN)The present invention provides novel crystalline forms of deferasirox, methods for their production, and methods for conversion of the novel forms to the known crystalline form I.
(FR)La présente invention concerne de nouvelles formes cristallines de déférasirox, des procédés pour leur production et des procédés pour la conversion des nouvelles formes de la forme cristalline I connue.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)